258 related articles for article (PubMed ID: 15577606)
1. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations.
Hengstman GJ; van Engelen BG; van Venrooij WJ
Curr Opin Rheumatol; 2004 Nov; 16(6):692-9. PubMed ID: 15577606
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
Mimori T; Imura Y; Nakashima R; Yoshifuji H
Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
[TBL] [Abstract][Full Text] [Related]
3. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
5. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP
Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431
[TBL] [Abstract][Full Text] [Related]
6. Myositis-specific autoantibodies: overview and recent developments.
Hengstman GJ; van Engelen BG; Vree Egberts WT; van Venrooij WJ
Curr Opin Rheumatol; 2001 Nov; 13(6):476-82. PubMed ID: 11698723
[TBL] [Abstract][Full Text] [Related]
7. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
8. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic myopathy.
Dankó K; Ponyi A; Molnar AP; András C; Constantin T
Curr Opin Rheumatol; 2009 Nov; 21(6):594-8. PubMed ID: 19730376
[TBL] [Abstract][Full Text] [Related]
10. Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis.
Brouwer R; Vree Egberts W; Jongen PH; van Engelen BG; van Venrooij WJ
Arthritis Rheum; 1998 Aug; 41(8):1428-37. PubMed ID: 9704641
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody profiles in the sera of European patients with myositis.
Brouwer R; Hengstman GJ; Vree Egberts W; Ehrfeld H; Bozic B; Ghirardello A; Grøndal G; Hietarinta M; Isenberg D; Kalden JR; Lundberg I; Moutsopoulos H; Roux-Lombard P; Vencovsky J; Wikman A; Seelig HP; van Engelen BG; van Venrooij WJ
Ann Rheum Dis; 2001 Feb; 60(2):116-23. PubMed ID: 11156543
[TBL] [Abstract][Full Text] [Related]
12. [Pathological features of myositis with myositis -specific autoantibodies].
Shimizu J; Mimori T
Rinsho Shinkeigaku; 2014; 54(12):1113-4. PubMed ID: 25672723
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.
Espada G; Maldonado Cocco JA; Fertig N; Oddis CV
J Rheumatol; 2009 Nov; 36(11):2547-51. PubMed ID: 19833756
[TBL] [Abstract][Full Text] [Related]
14. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.
Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H
Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881
[TBL] [Abstract][Full Text] [Related]
15. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
[TBL] [Abstract][Full Text] [Related]
17. Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Jobanputra R; Dankó K
Acta Reumatol Port; 2015; 40(4):337-47. PubMed ID: 26922197
[TBL] [Abstract][Full Text] [Related]
18. [Malignancy-associated myositis].
Shimizu J
Brain Nerve; 2010 Apr; 62(4):427-32. PubMed ID: 20420184
[TBL] [Abstract][Full Text] [Related]
19. The Jo-1 antibody system in myositis: relationships to clinical features and HLA.
Arnett FC; Hirsch TJ; Bias WB; Nishikai M; Reichlin M
J Rheumatol; 1981; 8(6):925-30. PubMed ID: 6977032
[TBL] [Abstract][Full Text] [Related]
20. Isolated necrotizing myopathy associated with ANTI-PL12 antibody.
Mehndiratta P; Mehta S; Manjila SV; Kammer GM; Cohen ML; Preston DC
Muscle Nerve; 2012 Aug; 46(2):282-6. PubMed ID: 22806380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
